Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches
- 1 August 2004
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 30 (5) , 451-459
- https://doi.org/10.1016/j.ctrv.2004.01.001
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Clinical implications of chromosomal abnormalities in gastric adenocarcinomasGenes, Chromosomes and Cancer, 2002
- Genetic progression in sporadic endometrial and gastrointestinal cancers with high microsatellite instabilityThe Journal of Pathology, 2002
- Molecular biology of gastric cancer*Seminars in Radiation Oncology, 2002
- Histone acetylation and retinoic acid receptor beta DNA Methylation as Novel Targets for Gastric Cancer TherapyDrug News & Perspectives, 2002
- Genetic differences between adenocarcinomas arising in Barrett's esophagus and gastric mucosaGastroenterology, 2001
- Evidence for two modes of allelic loss: multifocal analysis on both early and advanced gastric carcinomas.Virchows Archiv, 2001
- Distinct clinicopathologic and genetic profiles in sporadic gastric cancer with different mutator phenotypesGenes, Chromosomes and Cancer, 2000
- Genetic Alterations in Barrett Esophagus and Adenocarcinomas of the Esophagus and Esophagogastric Junction RegionThe American Journal of Pathology, 1998
- Frequent loss of heterozygosity of the long arm of chromosome 7 is closely associated with progression of human gastric carcinomasInternational Journal of Cancer, 1994
- Cytogenetic findings in eleven gastric carcinomasCancer Genetics and Cytogenetics, 1993